Replimune Group, Inc. (REPL) SEC filings
REPL SEC filings moved a median of -0.58% by the close. REPL SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the REPL overview →
30 measured REPL SEC filing events.
Where these REPL SEC filings landedvs 27 measured REPL SEC filing reactions
| Middle 50% of REPL SEC filing reactions | -1.95% to +3.05% |
|---|---|
| Median reaction (to close) | -0.58% |
| Measured reactions | 27 |
Point-in-time · zero look-ahead
Half of the 27 REPL SEC filing events with a measured close landed between -1.95% and +3.05%; 37% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Replimune Group, Inc. For: Sep 15 | SEC filing · Form 8-K | +0.68% | -2.13% | |
| Form 10-Q Replimune Group, Inc. For: Jun 30 | SEC filing · Form 10-Q | -1.95% | -0.14% | |
| Form 8-K Replimune Group, Inc. For: Aug 14 | SEC filing · Form 8-K | -0.59% | -1.45% | |
| Form S-3ASR Replimune Group, Inc. | SEC filing · Form S-3ASR | -1.95% | -0.14% | |
| Form 8-K/A Replimune Group, Inc. For: Aug 09 | SEC filing · Form 8-K | -1.79% | -0.15% | |
| Form 8-K Replimune Group, Inc. For: Aug 09 | SEC filing · Form 8-K | +0.83% | — | |
| Form 8-K Replimune Group, Inc. For: Aug 06 | SEC filing · Form 8-K | -1.23% | -7.23% | |
| Form 8-K Replimune Group, Inc. For: Jul 30 | SEC filing · Form 8-K | +7.79% | -0.89% | |
| Form 8-K Replimune Group, Inc. For: Jul 30 | SEC filing · Form 8-K | — | — | |
| Form EFFECT Replimune Group, Inc. | SEC filing · Form EFFECT | — | — | |
| Form ARS Replimune Group, Inc. For: Mar 31 | SEC filing · Form ARS | -1.07% | +3.05% | |
| Form DEF 14A Replimune Group, Inc. For: Sep 15 | SEC filing · Form DEF | -1.07% | +3.05% | |
| Form DEFA14A Replimune Group, Inc. | SEC filing · Form DEFA14A | -1.07% | +3.05% | |
| Form S-3/A Replimune Group, Inc. | SEC filing · Form S-3 | -3.63% | -0.69% | |
| Form PRE 14A Replimune Group, Inc. For: Sep 15 | SEC filing · Form PRE | -0.45% | -1.99% | |
| Form 10-K Replimune Group, Inc. For: Mar 31 | SEC filing · Form 10-K | -2.13% | -2.44% | |
| Form 8-K Replimune Group, Inc. For: Jun 29 | SEC filing · Form 8-K | -2.13% | -2.44% | |
| Form S-8 Replimune Group, Inc. | SEC filing · Form S-8 | -2.13% | -2.44% | |
| Form 8-K Replimune Group, Inc. For: Jun 26 | SEC filing · Form 8-K | -3.51% | +13.46% | |
| Form 8-K Replimune Group, Inc. For: May 29 | SEC filing · Form 8-K | +2.80% | +4.85% | |
| Form 8-K Replimune Group, Inc. For: Apr 10 | SEC filing · Form 8-K | -8.48% | -0.58% | |
| Form 10-Q Replimune Group, Inc. For: Dec 31 | SEC filing · Form 10-Q | +0.07% | +4.98% | |
| Form 8-K Replimune Group, Inc. For: Feb 03 | SEC filing · Form 8-K | +0.07% | +4.98% | |
| Form 8-K Replimune Group, Inc. For: Jan 12 | SEC filing · Form 8-K | -0.74% | +0.18% | |
| Form 10-Q Replimune Group, Inc. For: Sep 30 | SEC filing · Form 10-Q | -0.47% | -0.70% | |
| Form 8-K Replimune Group, Inc. For: Nov 06 | SEC filing · Form 8-K | -0.47% | -0.70% | |
| Form S-3/A Replimune Group, Inc. | SEC filing · Form S-3 | +2.94% | +1.84% | |
| Form 8-K Replimune Group, Inc. For: Oct 20 | SEC filing · Form 8-K | +7.74% | -1.92% | |
| Form 8-K Replimune Group, Inc. For: Sep 16 | SEC filing · Form 8-K | -16.63% | -16.02% | |
| Form 8-K Replimune Group, Inc. For: Sep 02 | SEC filing · Form 8-K | -1.18% | +6.93% |
Keep exploring
More REPL: earnings → · analyst actions → · REPL overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK) | 1,452 | +0.01% | 51% |
| GENMARK DIAGNOSTICS (GNMK) | 1,451 | +0.06% | 51% |
| Altimmune, Inc. (ALT) | 1,424 | 0.00% | 48% |
| PerkinElmer, Inc. (PKI) | 1,409 | +0.11% | 56% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.